Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Encainide
2. Encainide Hydrochloride, (+-)-isomer
3. Encainide, (+)-isomer
4. Encainide, (-)-isomer
5. Enkaid
6. Mj 9067
7. Mj-9067
8. Mj9067
1. 66794-74-9
2. Encainide Hcl
3. Enkaid
4. Encainide (hydrochloride)
5. Encainide Hydrochloride [usan]
6. Mj 9067-1
7. Mj-9067
8. Encainidehydrochloride
9. 4-methoxy-2'-(2-(1-methyl-2-piperidyl)ethyl)benzanilide Hydrochloride
10. (+-)-2'-(2-(1-methyl-2-piperidyl)ethyl)-p-anisanilide Monohydrochloride
11. 4ch7j36n9s
12. Chebi:59880
13. 4-methoxy-n-[2-[2-(1-methylpiperidin-2-yl)ethyl]phenyl]benzamide;hydrochloride
14. (+/-)-4-methoxy-n-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]benzamide Hydrochloride
15. Mj-9067-1
16. Encainide Hydrochloride (usan)
17. 2-(2-{2-[(4-methoxybenzoyl)amino]phenyl}ethyl)-1-methylpiperidinium Chloride
18. 4-methoxy-n-{2-[2-(1-methylpiperidin-2-yl)ethyl]phenyl}benzamide Hydrochloride
19. Enkade; Enkaid;benzamide, 4-methoxy-n-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]-, Monohydrochloride (9ci); Benzamide, 4-methoxy-n-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]-, Monohydrochloride, (+/-)-
20. Ncgc00185765-01
21. Unii-4ch7j36n9s
22. Mfcd01667688
23. Dsstox_cid_28930
24. Dsstox_rid_83196
25. Dsstox_gsid_49004
26. Mls004712064
27. Schembl121261
28. Chembl2106155
29. Dtxsid2049004
30. Encainide Hydrochloride [mi]
31. Tox21_113498
32. Nsc299238
33. Akos025311581
34. Encainide Hydrochloride [mart.]
35. Encainide Hydrochloride [vandf]
36. Nsc-299238
37. Encainide Hydrochloride [who-dd]
38. Benzamide, 4-methoxy-n-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, Monohydrochloride, (+-)-
39. Hy-12531
40. Smr002529683
41. Cas-66794-74-9
42. Cs-0011988
43. D03991
44. H11012
45. Encainide Hydrochloride, >=98% (hplc), Powder
46. Q27126935
47. 4-methoxy-2' -[2-(1-methyl- 2-piperidyl)athyl]benzanilid-hydrochlorid
48. (+/-)-2'-(2-(1-methyl-2-piperidyl)ethyl)-p-anisanilide Monohydrochloride
49. Benzamide, 4-methoxy-n-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, Monohydrochloride, (+/-)-
Molecular Weight | 388.9 g/mol |
---|---|
Molecular Formula | C22H29ClN2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 388.1917559 g/mol |
Monoisotopic Mass | 388.1917559 g/mol |
Topological Polar Surface Area | 41.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 434 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
ABOUT THIS PAGE
A Encainide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Encainide, including repackagers and relabelers. The FDA regulates Encainide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Encainide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Encainide supplier is an individual or a company that provides Encainide active pharmaceutical ingredient (API) or Encainide finished formulations upon request. The Encainide suppliers may include Encainide API manufacturers, exporters, distributors and traders.
click here to find a list of Encainide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Encainide DMF (Drug Master File) is a document detailing the whole manufacturing process of Encainide active pharmaceutical ingredient (API) in detail. Different forms of Encainide DMFs exist exist since differing nations have different regulations, such as Encainide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Encainide DMF submitted to regulatory agencies in the US is known as a USDMF. Encainide USDMF includes data on Encainide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Encainide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Encainide suppliers with USDMF on PharmaCompass.
Encainide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Encainide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Encainide GMP manufacturer or Encainide GMP API supplier for your needs.
A Encainide CoA (Certificate of Analysis) is a formal document that attests to Encainide's compliance with Encainide specifications and serves as a tool for batch-level quality control.
Encainide CoA mostly includes findings from lab analyses of a specific batch. For each Encainide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Encainide may be tested according to a variety of international standards, such as European Pharmacopoeia (Encainide EP), Encainide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Encainide USP).
LOOKING FOR A SUPPLIER?